Explore Blueprint Medicines's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Blueprint Medicines's official channels and fully traceable to its official company sources.
The table below lists all of Blueprint Medicines's' corporate disclosure by name and reporting period, ensuring full transparency and easy access. Coming soon, Tracenable users will be able to export disclosures as PDFs, view them in Markdown, or open them directly in ChatGPT or Claude for instant analysis and summarization.
| Name | Reporting Period | |
|---|---|---|
| 10-K | 2024 | |
| Financial & Extra-Financial Disclosure | 2024 | |
| Sustainability Report | 2023 | |
| Annual Report | 2023 | |
| Financial & Extra-Financial Disclosure | 2023 | |
| 10-K | 2022 | |
| Corporate Responsibility Report (CRR) | 2022 | |
| 10-K | 2021 | |
| Corporate Responsibility Report (CRR) | 2021 | |
| 10-K | 2020 | |
| 10-K | 2019 | |
| 10-K | 2018 | |
| 10-K | 2017 | |
| 10-K | 2016 | |
| 10-K | 2015 |